Copenhagen - Delayed Quote • DKK
BioPorto A/S (BIOPOR.CO)
At close: April 18 at 4:46 PM GMT+2
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in DKK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Peter Morch Eriksen B.B.A., BBA | CEO & Director | 292k | -- | 1960 |
| Prof. Lars Otto Uttenthal | Chief Scientific Officer | -- | -- | -- |
BioPorto A/S
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 29
Description
BioPorto A/S, an in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated clinical chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. BioPorto A/S was incorporated in 1917 and is based in Hellerup, Denmark.
Corporate Governance
BioPorto A/S’s ISS Governance QualityScore as of April 1, 2024 is 5. The pillar scores are Audit: 8; Board: 3; Shareholder Rights: 1; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
May 08, 2024
BioPorto A/S Earnings Call
Related Tickers
1QGEN.MI Qiagen N.V.
37.04
+0.09%
300639.SZ Guangdong Hybribio Biotech Co.,Ltd.
6.17
-1.28%
603108.SS Shanghai Runda Medical Technology Co., Ltd.
17.58
-1.79%
8037.HK China Biotech Services Holdings Limited
0.270
-1.82%
SPERM.ST Spermosens AB
0.1590
+2.58%
IMMNOV.ST Immunovia AB (publ)
1.7880
+1.94%
APDN Applied DNA Sciences, Inc.
0.3376
+1.38%
6661.TWO Welgene Biotech Co.,Ltd.
22.10
-1.78%
ISPC iSpecimen Inc.
0.4210
+97.65%
6615.TWO Sofiva Genomics Co.,Ltd.
40.65
0.00%